The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Uptake of dextran‐coated monocrystalline iron oxides in tumor cells and macrophages
Abstract
Although several dextran‐coated iron oxide preparations are in preclinical and clinical use, little is known about the mechanism of uptake into cells. As these particles have been shown to accumulate in macrophages and tumor cells, we performed cellular uptake and inhibition studies with a prototypical monocrystalline iron oxide nanoparticle (MION). MION particles were labeled with fluorescein isothiocyanate or radioiodinated and purified by gel permeation chromatography. Two preparations of MION particles were used in cell experiments: nontreated MION and plasma‐opsonized MION purified by gradient density purification. As determined by immunoblotting, opsonization resulted in C3, vitro‐nectin, and fibronectin association with MION. Incubation of cells with fluorescent MION showed active uptake of particles in macrophages both before and after opsonization. In C6 tumor cells, however, intracellular MION was only detectable in dividing cells. Quantitatively, 125 I‐labeled MION was internalized into cells with uptake values ranging from 17 ng (in 9L gliosarcoma) to 970 ng iron per million cells for peritoneal macrophages. Opsonization increased MION uptake into macrophages sixfold, whereas it increased the uptake in C6 tumor cells only twofold. Results from uptake inhibition assay suggest that cellular uptake of nonopsonized (dextran‐coated) MION particles is mediated by fluid‐phase endocytosis, whereas receptor‐mediated endocytosis is presumably responsible for the uptake of opsonized (protein‐coated) particles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils
Kodama, T., Freeman, M., Rohrer, L., Zabrecky, J., Matsudaira, P., & Krieger, M. (1990) · Nature · doi:10.1038/343531a0 · Cited by 1,041
Tumor interactions with the vasculature: angiogenesis and tumor metastasis
Blood, C. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(90)90014-r · Cited by 593
Professional and non-professional phagocytes: an introduction
Rabinovitch, M. (1995) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)88955-2 · Cited by 547
Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties
Shen, T., Weissleder, R., Papisov, M., Bogdanov, A., & Brady, T. J. (1993) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910290504 · Cited by 499
Self-citationLong-circulating iron oxides for MR imaging
Weissleder, R., Bogdanov, A., Neuwelt, E. A., & Papisov, M. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00033-4 · Cited by 398
Self-citationMagnetically labeled cells can be detected by MR imaging
Weissleder, R., Cheng, H., Bogdanova, A., & Bogdanov, A. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070140 · Cited by 336
Self-citationVesicle fusion following receptor-mediated endocytosis requires a protein active in Golgi transport
Diaz, R., Mayorga, L. S., Weidman, P. J., Rothman, J. E., & Stahl, P. D. (1989) · Nature · doi:10.1038/339398a0 · Cited by 251
Pratten, M. K., & Lloyd, J. B. (1986) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(86)90020-6 · Cited by 188
Surface functions during mitosis I: Phagocytosis, pinocytosis and mobility of surface-bound ConA
Berlin, R. D., Oliver, J. M., & Walter, R. J. (1978) · Cell · doi:10.1016/0092-8674(78)90002-8 · Cited by 184
Cellular Uptake and Trafficking of a Prototypical Magnetic Iron Oxide Label In Vitro
Schulze, E., Ferrucci, J. T., Poss, K., LAPOINTE, L., Bogdanova, A., & Weissleder, R. (1995) · Investigative Radiology · doi:10.1097/00004424-199510000-00006 · Cited by 142
Self-citation
Cited by
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
Massoud, T. F., & Gambhir, S. S. (2003) · Genes & Development · doi:10.1101/gad.1047403 · Cited by 2,216
Walkey, C. D., & Chan, W. C. W. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15233e · Cited by 1,758
Functionalisation of magnetic nanoparticles for applications in biomedicine
Berry, C. C., & Curtis, A. S. G. (2003) · Journal of Physics D: Applied Physics · doi:10.1088/0022-3727/36/13/203 · Cited by 1,588
Iron oxide MR contrast agents for molecular and cellular imaging
Bulte, J. W. M., & Kraitchman, D. L. (2004) · NMR in Biomedicine · doi:10.1002/nbm.924 · Cited by 1,500
Synthesis, Functionalization, and Biomedical Applications of Multifunctional Magnetic Nanoparticles
Hao, R., Xing, R., Xu, Z., Hou, Y., Gao, S., & Sun, S. (2010) · Advanced Materials · doi:10.1002/adma.201000260 · Cited by 1,372
Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles
Laurent, S., Dutz, S., Häfeli, U. O., & Mahmoudi, M. (2011) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2011.04.003 · Cited by 1,326
Magnetic nanoparticles for theragnostics
Shubayev, V. I., Pisanic, T. R., & Jin, S. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.007 · Cited by 1,028
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.006 · Cited by 956
Nanotechnology: Intelligent Design to Treat Complex Disease
Couvreur, P., & Vauthier, C. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0284-8 · Cited by 948
Imaging macrophages with nanoparticles
Weissleder, R., Nahrendorf, M., & Pittet, M. J. (2014) · Nature Materials · doi:10.1038/nmat3780 · Cited by 809
Hoehn, M., Küstermann, E., Blunk, J., Wiedermann, D., Trapp, T., Wecker, S., Föcking, M., Arnold, H., Hescheler, J., Fleischmann, B. K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242435499 · Cited by 707
Application of Nanotechnology in Cancer Therapy and Imaging
Wang, X., Yang, L., Chen, Z., & Shin, D. M. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0003 · Cited by 700
Wilhelm, C., Billotey, C., Roger, J., Pons, J. N., Bacri, J.-C., & Gazeau, F. (2003) · Biomaterials · doi:10.1016/s0142-9612(02)00440-4 · Cited by 675
Assessing the In Vitro and In Vivo Toxicity of Superparamagnetic Iron Oxide Nanoparticles
Mahmoudi, M., Hofmann, H., Rothen-Rutishauser, B., & Petri-Fink, A. (2012) · Chemical Reviews · doi:10.1021/cr2002596 · Cited by 617
Reimer, P., & Balzer, T. (2003) · European Radiology · doi:10.1007/s00330-002-1721-7 · Cited by 614
Nanotechnology for the biologist
McNeil, S. E. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0205074 · Cited by 613
Bulte, J. W. M., Zhang, S.-C., van Gelderen, P., Herynek, V., Jordan, E. K., Duncan, I. D., & Frank, J. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15256 · Cited by 531
Kunzmann, A., Andersson, B., Thurnherr, T., Krug, H., Scheynius, A., & Fadeel, B. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.04.007 · Cited by 527
Cellular responses to nanoparticles: Target structures and mechanisms
Unfried, K., Albrecht, C., Klotz, L.-O., Von Mikecz, A., Grether-Beck, S., & Schins, R. P. F. (2007) · Nanotoxicology · doi:10.1080/00222930701314932 · Cited by 503
Noninvasive cell-tracking methods
Kircher, M. F., Gambhir, S. S., & Grimm, J. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.141 · Cited by 501
Polysaccharide-decorated nanoparticles
Lemarchand, C., Gref, R., & Couvreur, P. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.02.016 · Cited by 500
Understanding and Overcoming Major Barriers in Cancer Nanomedicine
Nie, S. (2010) · Nanomedicine · doi:10.2217/nnm.10.23 · Cited by 498
Chemical Design of Biocompatible Iron Oxide Nanoparticles for Medical Applications
Ling, D., & Hyeon, T. (2013) · Small · doi:10.1002/smll.201202111 · Cited by 493
Biomimetic amplification of nanoparticle homing to tumors
Simberg, D., Duza, T., Park, J. H., Essler, M., Pilch, J., Zhang, L., Derfus, A. M., Yang, M., Hoffman, R. M., Bhatia, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610298104 · Cited by 471
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy
Dong, S. (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s2824 · Cited by 464
Bhatia, S. (2016) · Natural Polymer Drug Delivery Systems · doi:10.1007/978-3-319-41129-3_2 · Cited by 446
Kohler, N., Sun, C., Fichtenholtz, A., Gunn, J., Fang, C., & Zhang, M. (2006) · Small · doi:10.1002/smll.200600009 · Cited by 424
Hadjipanayis, C. G., Machaidze, R., Kaluzova, M., Wang, L., Schuette, A. J., Chen, H., Wu, X., & Mao, H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1022 · Cited by 419
Odyssey of a cancer nanoparticle: From injection site to site of action
Nichols, J. W., & Bae, Y. H. (2012) · Nano Today · doi:10.1016/j.nantod.2012.10.010 · Cited by 364
Karmali, P. P., & Simberg, D. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.554818 · Cited by 361
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
Fulci, G., Breymann, L., Gianni, D., Kurozomi, K., Rhee, S. S., Yu, J., Kaur, B., Louis, D. N., Weissleder, R., Caligiuri, M. A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605496103 · Cited by 357
Self-citationEffect of Nanoparticles on the Cell Life Cycle
Mahmoudi, M., Azadmanesh, K., Shokrgozar, M. A., Journeay, W. S., & Laurent, S. (2011) · Chemical Reviews · doi:10.1021/cr1003166 · Cited by 352
Tumoral Distribution of Long-circulating Dextran-coated Iron Oxide Nanoparticles in a Rodent Model
Moore, A., Marecos, E., Bogdanov, A., & Weissleder, R. (2000) · Radiology · doi:10.1148/radiology.214.2.r00fe19568 · Cited by 343
Self-citationIn vitro and in vivo behaviors of dextran functionalized graphene
Zhang, S., Yang, K., Feng, L., & Liu, Z. (2011) · Carbon · doi:10.1016/j.carbon.2011.05.056 · Cited by 332
Iron oxide nanoparticles for targeted cancer imaging and diagnostics
Rosen, J. E., Chan, L., Shieh, D.-B., & Gu, F. X. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.08.017 · Cited by 329
Towards clinically translatable in vivo nanodiagnostics
Park, S.-M., Aalipour, A., Vermesh, O., Yu, J. H., & Gambhir, S. S. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.14 · Cited by 327
Cell response to dextran-derivatised iron oxide nanoparticles post internalisation
Berry, C. C., Wells, S., Charles, S., Aitchison, G., & Curtis, A. S. G. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.12.046 · Cited by 313
Cai, H., An, X., Cui, J., Li, J., Wen, S., Li, K., Shen, M., Zheng, L., Zhang, G., & Shi, X. (2013) · ACS Applied Materials & Interfaces · doi:10.1021/am302883m · Cited by 306
Modo, M., Hoehn, M., & Bulte, J. W. M. (2005) · Molecular Imaging · doi:10.1162/15353500200505145 · Cited by 294
Wilhelm, C., Gazeau, F., Roger, J., Pons, J. N., & Bacri, J.-C. (2002) · Langmuir · doi:10.1021/la0257337 · Cited by 290
Floris, S., Blezer, E. L. A., Schreibelt, G., Döpp, E., van der Pol, S. M. A., Schadee‐Eestermans, I. L., Nicolay, K., Dijkstra, C. D., & de Vries, H. E. (2004) · Brain · doi:10.1093/brain/awh068 · Cited by 272
Morishige, K., Kacher, D. F., Libby, P., Josephson, L., Ganz, P., Weissleder, R., & Aikawa, M. (2010) · Circulation · doi:10.1161/circulationaha.109.891804 · Cited by 168
Self-citationPrediction of anti-cancer nanotherapy efficacy by imaging
Miller, M. A., Arlauckas, S., & Weissleder, R. (2017) · Nanotheranostics · doi:10.7150/ntno.20564 · Cited by 74
Self-citationMaarouf, A., Ferré, J.-C., Zaaraoui, W., Le Troter, A., Bannier, E., Berry, I., Guye, M., Pierot, L., Barillot, C., Pelletier, J., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458515607649 · Cited by 22
Metadata
- Authors
- Moore, A., Weissleder, R., & Bogdanov, A.
- Venue
- Journal of Magnetic Resonance Imaging
- Publisher
- Wiley
- Published
- 1997-11
- Volume
- 7
- Issue
- 6
- Pages
- 1140-1145
- ISSN
- 1053-1807 (ISSN-L)
- 1522-2586
- OpenAlex
- W2065191915
- Cited by
- 260
- References
- 23
- FWCI
- 3.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.